Rs 2,700 cancer drug selling for Rs 27,000: Supreme Court calls it daylight robbery

The Supreme Court has described the steep markup on essential cancer medicines as “daylight robbery” after being told that a drug available to retailers for Rs 2,700 carried a maximum retail price of Rs 27,000.

India Today4 sources1 min read3 days agoFiled September 22, 2026

How it developed

Every report in this story, oldest first.

ThePrintLatestSep 28, 2026, 3:02 PM
Systematic failure of authorities': SC takes suo motu cognisance of minor's gangrape in sleeper bus
India TodaySep 27, 2026, 6:00 AM
Karur Stampede Anniversary Observed; TN Govt Exempts Law And Order From RTI
Asomiya PratidinSep 26, 2026, 4:02 PM
‘সৰ্বসন্মতিক্ৰমে আয়োগে গ্ৰহণ কৰিছিল সকলো সিদ্ধান্ত...’
Hindustan TimesSep 26, 2026, 3:02 PM
EC extends deadline for claims, objections to October 12 in Maharashtra amid SIR row
Hindustan TimesSep 26, 2026, 2:02 PM
Got SIR notice over unmapped or logical discrepancies? EC explains what to do next
India TodaySep 26, 2026, 1:30 PM
Election Commission Dismisses Rift Claims, Extends SIR Deadlines in Delhi and Maharashtra
Hindustan TimesSep 25, 2026, 2:31 AM
SC seeks EC time frame for decision on TMC name, symbol dispute
India TodayBroke itSep 22, 2026, 6:30 PM
Rs 2,700 cancer drug selling for Rs 27,000: Supreme Court calls it daylight robbery

Get this in your inbox

Pick your topics and we will send one ranked edition a day.

Start free

Rs 2,700 cancer drug selling for Rs 27,000: Supreme Court calls it daylight robbery

How it developed

Related stories

Get this in your inbox